William Mack & Associates
ZBH icon

William Mack & Associates’s Zimmer Biomet ZBH Stock Holding History

William Mack & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.16K Buy
+13
New +$1.23K ﹤0.01% 694

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return

William Mack & Associates's ZBH Position: Q3 2026 in Review

William Mack & Associates opened a new position in Zimmer Biomet (ZBH) in Q3 2026: 13 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #694 among its holdings.

778 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • William Mack & Associates held 13 shares of Zimmer Biomet worth $1.16K as of Q3 2026.
  • Zimmer Biomet was a new William Mack & Associates position in Q3 2026.
  • Zimmer Biomet made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #694 holding.
  • 778 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.